Recent Finacing
Recent Raise
MyX Therapeutics commercializes MyX-001, a tunable biodegradable muco-adhesive nanoparticle platform for sustained drug release across mucosal routes (ocular, sublingual, intranasal, vaginal, GI), pursuing product-development licensing.
